At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 7 enrolled
Drug / intervention
tetracaine 4% gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Tetracaine (Ametop®) Compared to Placebo for Reducing Pain Associated With Intramuscular Injection of Palivizumab (Synagis®) - A Pilot Study
In Brief
A Phase 4 clinical trial evaluating tetracaine 4% gel and Placebo for Pain. Completed, enrolled 7 participants across 1 site.
Detailed Summary
This is a small study known as a pilot study. This pilot study is being done to see if a difference in pain from intramuscular palivizumab injection can be detected if tetracaine a topical numbing gel is used compared to no medication (placebo). If a difference is found in this pilot study, then a larger study may be done to confirm that there is a difference in pain experience.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesCanada
Collaborators--
Timeline
Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 2007
Enrollment StartNov 2007
Primary CompletionApr 2008
TodayJul 2026
First PostedJun 8, 2007
Enrollment StartNov 1, 2007
Primary CompletionApr 1, 2008
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 19.1 years ago
Interventions
tetracaine 4% geldrug
tetracaine applied prior to 1 injection
Placebodrug
placebo applied prior to 1 injection